-
INVASIVE MECHANICAL VENTILATION DURING TERMINAL LUNG CANCER HOSPITALIZATIONS: NATIONAL PATTERNS AND INPATIENT BURDEN
Feb 25, 2026, 14:41 PM -
COST-UTILITY OF PNEUMOCOCCAL VACCINATION STRATEGIES FOR ADULTS AGED 50 AND OLDER IN COLOMBIA: A MODEL-BASED ECONOMIC EVALUATION
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL IMPLANT INCORPORATING REAL-WORLD UTILIZATION DATA FROM A LARGE BRAZILIAN PRIVATE HEALTH INSURER
Feb 25, 2026, 14:41 PM -
THE MARKET FOR MONOCLONAL ANTIBODIES: TRENDS, CHALLENGES, AND OPPORTUNITIES
Feb 25, 2026, 14:41 PM -
INSIGHTS INTO RANGE OF MOTION (ROM) AND PHYSICAL FUNCTION (PF) CHANGES EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: RESULTS FROM EXIT INTERVIEWS
Feb 25, 2026, 14:41 PM -
PHARMACOECONOMIC EVALUATION OF DIFFERENT GONADOTROPIN-RELEASING HORMONE ANALOGS IN THE TREATMENT OF CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY IN CHINA
Feb 25, 2026, 14:41 PM -
DECODING THE PREDICTIVE ROLE OF COMPLETE RESPONSE/REMISSION RATE (CR) FOR OVERALL SURVIVAL (OS) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Feb 25, 2026, 14:41 PM -
ASSESSING QUALITY OF A LARGE LANGUAGE MODEL (LLM)-DERIVED PROSTATE CANCER (PC) REAL-WORLD DATASET: AN APPLICATION OF THE VALIDATION OF ACCURACY FOR LLM/ML-EXTRACTED INFORMATION AND DATA (VALID) FRAMEWORK
Feb 25, 2026, 14:41 PM -
COST-UTILITY OF TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR FOR CHRONIC HEPATITIS B IN INDIA: A MARKOV STATE-TRANSITION MODEL
Feb 25, 2026, 14:41 PM -
DEVELOPMENT AND EVALUATION OF CELLS, AN ENSEMBLE OF OPEN-WEIGHT LARGE LANGUAGE MODELS FOR SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:41 PM -
EXPLORATORY APPLICATION OF BIVARIATE NETWORK META-ANALYSIS TO PREDICT MISSING HAZARD RATIOS IN MCRPC USING SIMULATED CORRELATION DATA
Feb 25, 2026, 14:41 PM -
ACCELERATING EVIDENCE GENERATION: LEVERAGING LLMS FOR FULL-TEXT STUDY SELECTION
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS IN ADULTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA: A U.S. PAYER PERSPECTIVE MARKOV MODEL
Feb 25, 2026, 14:41 PM -
ADHERENCE TO ENDOCRINE THERAPY IN BREAST CANCER: A DETERMINANT OF OUTCOMES
Feb 25, 2026, 14:41 PM -
CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE COSTS OF DIFFUSE LARGE B-CELL LYMPHOMA IN COLOMBIA: A REAL-WORLD EVIDENCE STUDY
Feb 25, 2026, 14:41 PM -
A MULTI-COUNTRY RETROSPECTIVE CHART REVIEW OF TREATMENT PATTERNS AND RESOURCE USE IN PATIENTS WITH NEWLY DIAGNOSED PH-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA UNDERGOING FIRST-LINE CONSOLIDATION THERAPY
Feb 25, 2026, 14:41 PM -
THE FEASIBILITY OF MEASURING BTKI MEDICATION ADHERENCE IN THE TREATMENT OF CLL/SLL USING AN ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO) PLATFORM
Feb 25, 2026, 14:41 PM -
REAL-WORLD DATA ANALYSIS OF ONCOLOGICAL DRUG FUNDING AND ACCESS HETEROGENEITY IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Feb 25, 2026, 14:41 PM -
OVERVIEW OF THE EPIDEMIOLOGICAL AND ECONOMIC BURDEN OF CANCER IN THE MAGHREB
Feb 25, 2026, 14:41 PM -
IMPACT OF COMORBID DEPRESSION ON INSULIN INITIATION AND CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS: A MULTINATIONAL OHDSI COHORT STUDY
Feb 25, 2026, 14:41 PM
